These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27811020)

  • 1. Impact of CTLA4 genotype and other immune response gene polymorphisms on outcomes after single umbilical cord blood transplantation.
    Cunha R; Zago MA; Querol S; Volt F; Ruggeri A; Sanz G; Pouthier F; Kogler G; Vicario JL; Bergamaschi P; Saccardi R; Lamas CH; Díaz-de-Heredia C; Michel G; Bittencourt H; Tavella M; Panepucci RA; Fernandes F; Pavan J; Gluckman E; Rocha V;
    Blood; 2017 Jan; 129(4):525-532. PubMed ID: 27811020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
    Sanz J; Jaramillo FJ; Planelles D; Montesinos P; Lorenzo I; Moscardó F; Martin G; López F; Martínez J; Jarque I; de la Rubia J; Larrea L; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):106-10. PubMed ID: 24516896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.
    Eapen M; Wang T; Veys PA; Boelens JJ; St Martin A; Spellman S; Bonfim CS; Brady C; Cant AJ; Dalle JH; Davies SM; Freeman J; Hsu KC; Fleischhauer K; Kenzey C; Kurtzberg J; Michel G; Orchard PJ; Paviglianiti A; Rocha V; Veneris MR; Volt F; Wynn R; Lee SJ; Horowitz MM; Gluckman E; Ruggeri A
    Lancet Haematol; 2017 Jul; 4(7):e325-e333. PubMed ID: 28623181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
    Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
    Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.
    Eapen M; Klein JP; Sanz GF; Spellman S; Ruggeri A; Anasetti C; Brown M; Champlin RE; Garcia-Lopez J; Hattersely G; Koegler G; Laughlin MJ; Michel G; Nabhan SK; Smith FO; Horowitz MM; Gluckman E; Rocha V; ; ;
    Lancet Oncol; 2011 Dec; 12(13):1214-21. PubMed ID: 21982422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.
    Eapen M; Klein JP; Ruggeri A; Spellman S; Lee SJ; Anasetti C; Arcese W; Barker JN; Baxter-Lowe LA; Brown M; Fernandez-Vina MA; Freeman J; He W; Iori AP; Horowitz MM; Locatelli F; Marino S; Maiers M; Michel G; Sanz GF; Gluckman E; Rocha V;
    Blood; 2014 Jan; 123(1):133-40. PubMed ID: 24141369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
    Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
    Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
    Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
    Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
    Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial.
    Koreth J; Kim HT; Lange PB; Bindra B; Reynolds CG; Chammas MJ; Armand P; Cutler CS; Ho VT; Glotzbecker B; Nikiforow S; Ritz J; Blazar BR; Soiffer RJ; Antin JH; Alyea EP
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1907-13. PubMed ID: 26055298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
    Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "No wash" albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment.
    Dahi PB; Ponce DM; Devlin S; Evans KL; Lubin MN; Gonzales AM; Tonon J; Meagher R; Giralt S; Kernan NA; Scaradavou A; Barker JN
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):490-4. PubMed ID: 24361912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic Disorders.
    Mallhi KK; Smith AR; DeFor TE; Lund TC; Orchard PJ; Miller WP
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):119-125. PubMed ID: 27989932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
    Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
    J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
    Sanz J; Boluda JC; Martín C; González M; Ferrá C; Serrano D; de Heredia CD; Barrenetxea C; Martinez AM; Solano C; Sanz MA; Sanz GF;
    Bone Marrow Transplant; 2012 Oct; 47(10):1287-93. PubMed ID: 22327127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The impact of HLA matching on outcome of single unit unrelated cord blood transplantation: a retrospective single center clinical analysis].
    Sun G; Sun Z; Liu H; Zheng C; Tang B; Zhu X; Song K
    Zhonghua Xue Ye Xue Za Zhi; 2014 Aug; 35(8):678-83. PubMed ID: 25152111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.